Bill

Bill > S1356


FL S1356

FL S1356
Florida Institute for Pediatric Rare Diseases


summary

Introduced
02/26/2025
In Committee
03/06/2025
Crossed Over
Passed
Dead
06/16/2025

Introduced Session

2025 Regular Session

Bill Summary

An act relating to the Florida Institute for Pediatric Rare Diseases; creating s. 1004.4211, F.S.; establishing the Florida Institute for Pediatric Rare Diseases within the Florida State University College of Medicine; providing the purpose of the institute; providing the goals of the institute; requiring the institute to establish and administer the Sunshine Genetics Pilot Program for a specified period; providing the purpose of the pilot program; providing institute responsibilities and duties relating to the pilot program; providing requirements for participation in the pilot program and data collection and release in the pilot program; defining the term “health care practitioner”; providing reporting requirements for the pilot program; establishing the Sunshine Genetics Consortium for specified purposes; requiring the consortium to be administered at the institute by an oversight board; providing for the membership and terms of the board; providing reporting requirements for the consortium; specifying that implementation of the act is subject to appropriation; providing an effective date.

AI Summary

This bill establishes the Florida Institute for Pediatric Rare Diseases within Florida State University's College of Medicine, with the primary purpose of improving health outcomes for children with rare diseases through research, clinical care, education, and advocacy. The institute will create the Sunshine Genetics Pilot Program, a 5-year voluntary newborn genetic screening initiative that includes whole genome sequencing, where parents must provide consent for participation. The program will collect and securely store genetic data, which will be shared in a deidentified format with researchers. Additionally, the bill creates the Sunshine Genetics Consortium, a network of clinical and academic professionals from state universities and children's hospitals aimed at advancing genetic research, developing precision medicine, and supporting families with children diagnosed with genetic disorders. The consortium will be overseen by a board comprising representatives from various medical schools, children's hospitals, and governmental appointees, who will meet at least twice annually and provide annual reports to state leadership. The implementation of these initiatives is contingent upon available state appropriations, with the act set to take effect on July 1, 2025.

Committee Categories

Budget and Finance

Sponsors (2)

Other Sponsors (2)

Education Postsecondary (S), Fiscal Policy (S)

Last Action

Laid on Table, companion bill(s) passed, see CS/CS/HB 907 (Ch. 2025-187) (on 04/30/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...